Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) was the recipient of a significant increase in short interest during the month of July. As of July 15th, there was short interest totaling 5,250,294 shares, an increase of 75.3% from the June 30th total of 2,994,254 shares. Approximately 25.3% of the shares of the company are sold short. Based on an average daily trading volume, of 15,841,226 shares, the days-to-cover ratio is presently 0.3 days.
Wall Street Analyst Weigh In
A number of analysts have recently issued reports on RKTO shares. Wall Street Zen cut Rocket One Inc. Common Stock from a “sell” rating to a “strong sell” rating in a research report on Saturday, July 18th. Weiss Ratings raised Rocket One Inc. Common Stock from a “sell (e+)” rating to a “sell (d-)” rating in a report on Tuesday, June 23rd. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $5.00.
Read Our Latest Stock Analysis on RKTO
Rocket One Inc. Common Stock Stock Performance
Rocket One Inc. Common Stock (NASDAQ:RKTO – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.17) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.03).
Hedge Funds Weigh In On Rocket One Inc. Common Stock
Several institutional investors and hedge funds have recently made changes to their positions in RKTO. Lido Advisors LLC acquired a new stake in Rocket One Inc. Common Stock during the 3rd quarter worth approximately $32,000. Kestra Private Wealth Services LLC acquired a new position in Rocket One Inc. Common Stock in the 3rd quarter valued at $51,000. Virtu Financial LLC acquired a new position in Rocket One Inc. Common Stock in the 3rd quarter valued at $184,000. Geode Capital Management LLC increased its position in Rocket One Inc. Common Stock by 8.0% during the 2nd quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock worth $143,000 after buying an additional 9,071 shares during the period. Finally, Citadel Advisors LLC acquired a new stake in shares of Rocket One Inc. Common Stock during the third quarter worth $232,000. Institutional investors and hedge funds own 7.08% of the company’s stock.
Rocket One Inc. Common Stock Company Profile
Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.
Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.
Featured Stories
- Five stocks we like better than Rocket One Inc. Common Stock
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
- MarketBeat Week in Review – 07/27- 07/31
Receive News & Ratings for Rocket One Inc. Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rocket One Inc. Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
